Latest filing published 07 Jun 2021 for Nexien Biopharma, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lindy Snider: trading record in brief
Lindy Snider, listed as board member, appears in our data through filings on Nexien Biopharma, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 19 June 2018 to 7 June 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 7 June 2021 came the latest disclosure, a share grant in Nexien Biopharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lindy Snider
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 sharesCommon stockSEC:0001214659-21-006371:0
1 of 1 declaration